Parallel Tracking i-biomarkerT Development with Drug Development for Maximum Benefit

Video   Jul 07, 2015

 

Molecular imaging is increasingly being used to support decision-making in early-stage drug development, particularly in the CNS. Providing invaluable information on the so-called ‘three pillars of drug survival’, namely tissue delivery, target engagement and pharmacological effect, it can be seen as a kind of precision pharmacology However, a lack of appreciation of when and how to use imaging and a lack of suitable tools means imaging is often an afterthought and employed in a post-mortem of drug failure. Timely development of imaging biomarkers will ensure the full translational value of this technology can be realised 

 
 
 
 

Recommended Videos

Prof. Anna Williams Discusses Her Research into Small Vessel Disease

Video

Professor Anna Williams spoke to Xandrina and Adam on the Neuro Show to explain how her group's findings are being translated into treatment for Small Vessel Disease.

WATCH NOW

Pill for Better Diagnosis of Breast Cancer

Video

Researchers from the University of Michigan have developed a diagnostic imaging pill enabling the early and more accurate diagnosis of cancerous tumors in breast tissue.

WATCH NOW

Research-grade Q-TOF LCMS-9030

Video

Shimadzu’s research-grade LCMS-9030 quadrupole time-of-flight (Q-TOF) mass spectrometer combines the engineering DNA from our proven triple quadrupole (LC-MS/MS) platform with powerful, new TOF architecture to transform high mass accuracy workflows.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Analysis & Separations Diagnostics Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy